Literature DB >> 16850110

Potential clinical role of FDG-PET in detecting sarcomatous transformation in von Recklinghausen's disease: a case study and review of the literature.

Sandip Basu1, Narendra Nair.   

Abstract

BACKGROUND: The diagnosis of sarcomatous transformation of plexiform neurofibromas in Neurofibromatosis-1 (NF 1) is a clinical and radiological challenge. Considerable overlap exists in the clinical and the radiological characteristics between the benign enlarging neurofibromas and their counterparts undergoing malignant changes. Surgical biopsy to rule out suspicious malignant transformation is often a problem in deep seated lesions.
METHODS: We, in this paper, explore the clinical utility of FDG-PET in detecting and assessing this life threatening complication of neurofibromas. A case is described with FDG-PET and MRI documentation of such transformation and subsequent histopathological correlation. The case upholds the potential advantages of a FDG-PET over the conventional imaging modalities. A review of the existing literature is also carried out; a total of four published reports on this issue were identified in English literature by searches of Pubmed. RESULTS AND
CONCLUSION: FDG-PET appeared a reliable as well as sensitive noninvasive technique that might minimize unnecessary deep surgical biopsy to rule out malignant transformation in cases of NF-1 with features of enlargement of a preexisting peripheral nerve sheath tumour, pain or neurodeficit.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16850110     DOI: 10.1007/s11060-006-9161-x

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  14 in total

Review 1.  Type 1 neurofibromatosis and the pediatric patient.

Authors:  V M Riccardi
Journal:  Curr Probl Pediatr       Date:  1992-02

2.  Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.

Authors:  T N Basu; D H Gutmann; J A Fletcher; T W Glover; F S Collins; J Downward
Journal:  Nature       Date:  1992-04-23       Impact factor: 49.962

3.  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.

Authors: 
Journal:  Arch Neurol       Date:  1988-05

4.  Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.

Authors:  R E Ferner; J D Lucas; M J O'Doherty; R A Hughes; M A Smith; B F Cronin; J Bingham
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

5.  Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children.

Authors:  K DeBella; J Szudek; J M Friedman
Journal:  Pediatrics       Date:  2000-03       Impact factor: 7.124

6.  Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17.

Authors:  D Barker; E Wright; K Nguyen; L Cannon; P Fain; D Goldgar; D T Bishop; J Carey; B Baty; J Kivlin
Journal:  Science       Date:  1987-05-29       Impact factor: 47.728

7.  Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients.

Authors:  J M Friedman; P H Birch
Journal:  Am J Med Genet       Date:  1997-05-16

8.  Retroperitoneal malignant peripheral nerve sheath tumor: evaluation with serial FDG-PET.

Authors:  Subhash Chander; Steven M Westphal; Imad T Zak; David A Bloom; Alkis P Zingas; Richard N Joyrich; Peter J Littrup; Jeffrey W Taub; Todd M Getzen
Journal:  Clin Nucl Med       Date:  2004-07       Impact factor: 7.794

Review 9.  The neurofibromatosis type 1 gene and its protein product, neurofibromin.

Authors:  D H Gutmann; F S Collins
Journal:  Neuron       Date:  1993-03       Impact factor: 17.173

10.  Identification and characterization of the neurofibromatosis type 1 protein product.

Authors:  J E DeClue; B D Cohen; D R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

View more
  4 in total

1.  [18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation.

Authors:  L L Tsai; L Drubach; F Fahey; M Irons; S Voss; N J Ullrich
Journal:  J Neurooncol       Date:  2012-03-11       Impact factor: 4.130

2.  The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression.

Authors:  Michael J Fisher; Sandip Basu; Eva Dombi; Jian Q Yu; Brigitte C Widemann; Avrum N Pollock; Avital Cnaan; Hongming Zhuang; Peter C Phillips; Abass Alavi
Journal:  J Neurooncol       Date:  2007-12-11       Impact factor: 4.130

3.  The correlation between clinical, nuclear and histologic findings in a patient with Von Recklinghausen's disease.

Authors:  Justus-Martijn Brinkman; Johannes L Bron; Paul Ijm Wuisman; Paul J van Diest; Emile Fi Comans; Carla Fm Molthoff
Journal:  World J Surg Oncol       Date:  2007-11-12       Impact factor: 2.754

Review 4.  Masses of developmental and genetic origin affecting the paediatric craniofacial skeleton.

Authors:  Salvatore Stefanelli; Pravin Mundada; Anne-Laure Rougemont; Vincent Lenoir; Paolo Scolozzi; Laura Merlini; Minerva Becker
Journal:  Insights Imaging       Date:  2018-05-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.